Target Name: LOC105372710
NCBI ID: G105372710
Review Report on LOC105372710 Target / Biomarker Content of Review Report on LOC105372710 Target / Biomarker
LOC105372710
Other Name(s): LOC105372710 variant X5 | Uncharacterized LOC105372710, transcript variant X5 | Uncharacterized LOC105372710 | uncharacterized LOC105372710

LOC105372710: A Promising Drug Target for Neurodegenerative and Cancer

LOC105372710 (LOC105372710 variant X5) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the LOC105372710 gene family, which encodes a protein known as X5.

X5 is a 21-kDa protein that is involved in various cellular processes, including cell signaling, cell adhesion, and neurotransmitter release. It is highly conserved and has been identified as a potential drug target in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of X5 is its role in cell signaling. X5 is a scaffold protein that can interact with various signaling molecules, including tyrosine kinases and G-protein-coupled receptors. It helps to regulate the activity of these molecules and is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

In neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, X5 has been shown to be involved in the development and progression of neurodegeneration. Studies have shown that X5 levels are elevated in the brains of individuals with these disorders, and that inhibition of X5 has has been shown to protect against neurodegeneration in animal models of these diseases.

X5 is also involved in cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs.

In cancer, X5 is also considered a potential drug target. Studies have shown that the expression level of X5 is closely related to the prognosis and treatment response of various cancers. For example, patients with high levels of X5 expression tend to have worse survival rates, while patients with tumors with low levels of X5 expression are less sensitive to chemotherapy. Therefore, reducing X5 levels may be a promising cancer treatment strategy.

In addition, X5 is also associated with the release of neurotransmitters. Neurotransmitters are chemicals that carry signaling molecules between neurons. X5 plays an important role in the survival and function of neurons and also plays a key role in neuronal apoptosis.

Overall, LOC105372710 (LOC105372710 variant X5) is a very promising drug target. By inhibiting the expression of X5, many neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, can be treated. In addition, it can also be used as a cancer treatment strategy to treat various cancers.

Protein Name: Uncharacterized LOC105372710

The "LOC105372710 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372710 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037